-
EP2941245
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2941245
| EP2941245 - DELAYED-RELEASE COMPOSITION COMPRISING BIGUANIDE [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 24.05.2024 Database last updated on 03.09.2024 | |
| Former | Grant of patent is intended Status updated on 17.01.2024 | ||
| Former | Examination is in progress Status updated on 22.12.2023 | ||
| Former | Grant of patent is intended Status updated on 21.08.2023 | ||
| Former | Examination is in progress Status updated on 16.01.2017 | Most recent event Tooltip | 27.06.2024 | Change - divisional application(s) | published on 31.07.2024 [2024/31] | Applicant(s) | For all designated states Anji Pharmaceuticals Inc. 245 Main Street Cambridge, MA 02142 / US | [2023/15] |
| Former [2020/03] | For all designated states Anji Pharma (US) LLC 4 Dana Road Boxford, MA 01921 / US | ||
| Former [2015/46] | For all designated states Elcelyx Therapeutics, Inc. 11975 El Camino Real Suite 305 San Diego, CA 92130 / US | Inventor(s) | 01 /
BARON, Alain D. 12863 Baywind Point San Diego, CA 92130 / US | 02 /
FINEMAN, Mark S. 12444 Oakfort Place San Diego, CA 92131 / US | 03 /
KIM, Terri 3209 Avenida De Sueno Carlsbad, CA 92009 / US | 04 /
DORDUNOO, Stephen Kwaku c/o Kydes Pharmaceutical, LLC 1450 South Rolling Road Halethorpe, MD 21227 / US | [2024/26] |
| Former [2015/46] | 01 /
BARON, Alain D. 12863 Baywind Point San Diego, CA 92130 / US | ||
| 02 /
FINEMAN, Mark S. 12444 Oakfort Place San Diego, CA 92131 / US | |||
| 03 /
KIM, Terri 3209 Avenida De Sueno Carlsbad, CA 92009 / US | |||
| 04 /
DORDUNOO, Stephen Kwaku c/o Kydes Pharmaceutical LLC 1450 South Rolling Road Halethorpe, MD 21227 / US | Representative(s) | Ricker, Mathias Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Partnerschaft mbB Zweibrückenstraße 5-7 80331 München / DE | [2024/26] |
| Former [2015/46] | Ricker, Mathias Wallinger Ricker Schlotter Tostmann Patent- und Rechtsanwälte Zweibrückenstrasse 5-7 80331 München / DE | Application number, filing date | 14702108.3 | 03.01.2014 | [2015/46] | WO2014US10240 | Priority number, date | US201361749307P | 05.01.2013 Original published format: US 201361749307 P | [2015/46] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2014107617 | Date: | 10.07.2014 | Language: | EN | [2014/28] | Type: | A1 Application with search report | No.: | EP2941245 | Date: | 11.11.2015 | Language: | EN | The application published by WIPO in one of the EPO official languages on 10.07.2014 takes the place of the publication of the European patent application. | [2015/46] | Type: | B1 Patent specification | No.: | EP2941245 | Date: | 26.06.2024 | Language: | EN | [2024/26] | Search report(s) | International search report - published on: | EP | 10.07.2014 | Classification | IPC: | A61K9/28, A61K31/155, A61P1/12, A61P1/18, A61P3/00, A61P1/00, A61P3/10, A61P43/00 | [2023/37] | CPC: |
A61K9/2886 (EP,IL,US);
A61K31/155 (EP,IL,US);
A61K9/2846 (IL,US);
A61P1/00 (EP,IL);
A61P1/12 (EP,IL);
A61P1/18 (EP,IL);
A61P3/00 (EP,IL);
A61P3/04 (EP,IL);
A61P3/10 (EP,IL);
A61P43/00 (EP,IL)
(-)
|
| Former IPC [2015/46] | A61K9/28, A61K31/155 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/46] | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | BIGUANIDFORMULIERUNG MIT VERZÖGERTER FREISETZUNG | [2023/37] | English: | DELAYED-RELEASE COMPOSITION COMPRISING BIGUANIDE | [2015/46] | French: | FORMULATION À LIBÉRATION RETARDÉE COMPRENANT DE BIGUANIDE | [2023/37] |
| Former [2015/46] | RETARD-ZUSAMMENSETZUNG MIT BIGUANID | ||
| Former [2015/46] | COMPOSITIONS ET MÉTHODES PERMETTANT DE TRAITER DES AFFECTIONS MÉTABOLIQUES | Entry into regional phase | 05.08.2015 | National basic fee paid | 05.08.2015 | Designation fee(s) paid | 05.08.2015 | Examination fee paid | Examination procedure | 05.08.2015 | Examination requested [2015/46] | 24.03.2016 | Amendment by applicant (claims and/or description) | 05.09.2016 | Despatch of a communication from the examining division (Time limit: M06) | 20.06.2017 | Reply to a communication from the examining division | 18.09.2018 | Despatch of a communication from the examining division (Time limit: M06) | 26.04.2019 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 05.07.2019 | Reply to a communication from the examining division | 18.08.2020 | Despatch of a communication from the examining division (Time limit: M06) | 25.02.2021 | Reply to a communication from the examining division | 05.08.2021 | Despatch of a communication from the examining division (Time limit: M04) | 25.08.2021 | Reply to a communication from the examining division | 22.08.2023 | Communication of intention to grant the patent | 21.12.2023 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 18.01.2024 | Communication of intention to grant the patent | 15.05.2024 | Fee for grant paid | 15.05.2024 | Fee for publishing/printing paid | 15.05.2024 | Receipt of the translation of the claim(s) | Divisional application(s) | EP24184490.1 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 05.09.2016 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 05.07.2019 | Request for further processing filed | 05.07.2019 | Full payment received (date of receipt of payment) Request granted | 19.07.2019 | Decision despatched | The application is deemed to be withdrawn due to failure to reply to the examination report | 20.06.2017 | Request for further processing filed | 20.06.2017 | Full payment received (date of receipt of payment) Request granted | 03.07.2017 | Decision despatched | Fees paid | Renewal fee | 11.01.2016 | Renewal fee patent year 03 | 11.01.2017 | Renewal fee patent year 04 | 04.01.2018 | Renewal fee patent year 05 | 15.01.2019 | Renewal fee patent year 06 | 14.01.2020 | Renewal fee patent year 07 | 13.01.2021 | Renewal fee patent year 08 | 16.12.2021 | Renewal fee patent year 09 | 29.11.2022 | Renewal fee patent year 10 | 29.11.2023 | Renewal fee patent year 11 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US2006222709 (DEVANE JOHN [IE]); | [XY]US2012177730 (BARON ALAIN D [US], et al); | [XP]WO2013103919 (ELCELYX THERAPEUTICS INC [US]); | by applicant | US3536809 | US3598123 | US3845770 | US3916899 | US4008719 | US4036948 | US5059595 | US5073543 | US5120548 | US5135757 | US5354556 | US5591767 | US5603957 | US5639476 | US5674533 | US5733566 | US5846566 | US5891919 | US6022562 | US6245356 | US6376657 | US2004138189 | US6773720 | US2006019346 | US2006024335 | US2006172020 | US2006269617 | US2006275765 | US2007037212 | US2007104805 | US7247427 | WO2007116404 | WO2008000063 | US2008003268 | US2008050499 | US2008108604 | US2008187936 | US7416867 | US2009042813 | US2010056621 | US2010130498 | WO2010060198 | WO2010076879 | US2010184796 | US7807204 | US7811788 | US7829299 | US2010316736 | US2010330205 | WO2011012298 | US2011119499 | US2011124609 | WO2011068814 | US2011143376 | US2011152361 | WO2011085979 | US2011217394 | US2011293753 | US2011311991 | WO2011157692 | WO2011163183 |